Published on 29 Mar 2024 on Simply Wall St. via Yahoo Finance
Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain
While Corcept Therapeutics Incorporated (NASDAQ:CORT) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 22% in the last quarter. But that doesn't change the fact that shareholders have received really good returns over the last five years. In fact, the share price is 114% higher today. To some, the recent pullback wouldn't be surprising after such a fast rise. Of course, that doesn't necessarily mean it's cheap now.
So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.
View our latest analysis for Corcept Therapeutics